Navigation Links
Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Date:1/8/2008

hion, reaching maximal effect at 125 mg. Further, no diminution of morphine-induced miosis, a CNS effect, was observed at single oral doses of NKTR-118 that produced a maximal effect on gastrointestinal transit time. NKTR-118 was well-tolerated and rapidly absorbed with dose proportional pharmacokinetics over single dose ranges of 8-1,000 mg.

According to IMS Health, more than 200 million prescriptions were written for opioids in 2006 in the United States, alone. Many studies indicate that a high percentage of patients receiving opioids are likely to experience significant constipation and other symptoms of OBD. Stool softeners or laxatives may be inadequate for many patients with OIC and often are associated with unwanted side effects such as bloating and cramping.

Data Presentations for NKTR-118

Study results from Phase 1 and preclinical trials for NKTR-118 were presented at the American College of Clinical Pharmacology conference and the American Academy of Pain Management's Annual Clinical Meeting in September 2007. These presentations can be found at: http://www.nektar.com/wt/page/nktr118_media

About Nektar

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development platforms. Nektar PEGylation and pulmonary technology, expertise, and manufacturing capabilities have enabled ten approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.

This press release contains forward-looking statements that reflect the company's current views as to the value, relative competitive position,
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
3. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
4. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
7. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
8. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
9. Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
10. Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity
11. Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... Company"), a specialty pharmaceutical company focused on pharmaceuticals for ... the 27th Annual ROTH Conference, which will take place ... Dana Point, California . Management,s presentation ... a.m. Pacific Time (12:00 p.m. Eastern Time) in the ...
(Date:3/3/2015)... Spain , March 3, 2015  AT&T 1 ... PHIA) today announced that  AT&T  is the connectivity provider ... GoSafe was designed to help provide peace of mind ... them the freedom to live active lives with the ... they need it. The AT&T network 2 helps ...
(Date:3/3/2015)... 3, 2015 Today, the Partnership for ... America,s biopharmaceutical research companies, unveiled a redesigned ... provide patients and caregivers with faster, easier access ... private patient assistance programs. Since ... platform to engage, educate and empower patients and ...
Breaking Medicine Technology:AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 2
... Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) today ... Officer of Savient will present at the Cowen and Company ... 6, 2012 at 10:40 AM Eastern Time.  The conference will ... MA. A live webcast of the presentation can ...
... Annual National Mobility Equipment Dealers Association (NMEDA) Conference in ... which will be celebrated throughout the U.S. and Canada ... is to teach seniors, veterans and people with disabilities ... the use of wheelchair accessible vehicles and adaptive mobility ...
Cached Medicine Technology:Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference 2NMEDA Introduces National Mobility Awareness Month for Seniors, Veterans and People with Disabilities 2
(Date:3/3/2015)... While it is clear that the ... young Canadian drivers are signing up to UBI policies, ... to be enticed. Due to current regulations, the application ... form. Its full capability is starting to be ... maintenance, emergency breakdown services are at the top of ...
(Date:3/3/2015)... Today is International Ear Care Day, and the ... applaud and promote the launch of Make Listening Safe, ... for stemming the threat of noise-induced hearing loss. , ... practice safe listening when they recreate, be that listening ... or engaging in other forms of entertainment. , ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The Calistoga Chamber ... “Mudder of All Weekends,” taking place Friday, March 27, through ... hunt, Pretty Muddy 5K fun run, restaurant and bar crawl, ... is open to women, ages 14 and older. , A ... are getting in on the action by offering Mudder of ...
(Date:3/3/2015)... Ann Arbor, MI (PRWEB) March 03, 2015 ... on NPR News Morning Edition, science correspondent Shankar Vedantam ... the University of Pennsylvania about the drastic decrease in hand-hygiene ... shift. He suggested that the problem could be solved in ... to perform hand hygiene when they enter and exit a ...
(Date:3/3/2015)... 2015 OncLive® and Indiana University ... forces to share news about the center’s research ... is part of OncLive’s Strategic Alliance Partnership initiative. ... and marketing teams will partner with the IU ... center, to highlight accomplishments. They include the center’s ...
Breaking Medicine News(10 mins):Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 2Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 3Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3
... Institute for Evolutionary Anthropology, Leipzig, Germany, have investigated evidence ... ,Debates about altruism are often based on the assumption ... the human version differs from that of other animals ... and colleagues have found evidence that chimpanzees act altruistically ...
... that smoking may hamper alcoholics neurocognitive recovery during their first ... ,About 50 to 90 percent of individuals in ... new findings show that smoking may interfere with the neurocognitive ... months of abstinence from alcohol. ,The results ...
... annual UN report on illegal drugs has said that opium ... ,The World Drug Report says over 90 percent of ... Afghanistan. ,According to a BBC report, the ... the presence of more than 30,000 international troops there, and ...
... have discovered that attaching polymeric nanoparticles to the ... in vivo lifetime of the nanoparticles. ... drugs. They protect drugs from degradation until they ... drugs. Polymeric nanoparticles, however, suffer from one major ...
... The Kenyan governmment said Tuesday the rate of HIV/AIDS infections had ... major challenge in the country. ,The state-run National ... in 2004 to the current 5.9 percent of the country's nearly ... in new infections from 85,000 in 2004 to 60,000 in 2005 ...
... in the egg cells of the Northern Leopard frog (Rana ... for brain tumours. ,The molecule Amphinase,recognises the ... its surface before invading the cell and inactivating the RNA ... new research published in the Journal of Molecular Biology, scientists ...
Cached Medicine News:Health News:Smoking Hampers Alcoholics' Neurocognitive Recovery During Abstinence 2Health News:Smoking Hampers Alcoholics' Neurocognitive Recovery During Abstinence 3Health News:Adherence of Nanoparticles to RBC- Very Effective Drug Delivery Method 2Health News:Brain Tumor Drug in Frogs A New Report 2
This product is for the lower body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
CritiCool™ offers precise cooling to the programmed target temperature by applying temperature control algorithm....
Medicine Products: